BSX 8-K 2026-09-23
BOSTON SCIENTIFIC CORP (BSX) 8-K dated 2026-09-23 — accession 0000885725-26-000061.
BOSTON SCIENTIFIC CORP (BSX) is a medical devices company listed on US.
BOSTON SCIENTIFIC CORP filed a 8-K on 2026-09-23. Accession 0000885725-26-000061.
This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. Revenue was up 19.9% from 2024-12-31 to 2025-12-31. BSX currently screens at market cap $71.81B and trailing P/E 18.5.
Not investment advice. The BSX SEC hub lists recent forms. The stock page is the research view.